Pharmaceuticals in Germany

Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Germany pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2014 annual average exchange rates.

The German pharmaceuticals market had total revenues of $37.1bn in 2014, representing a compound annual growth rate (CAGR) of 0.9% between 2010 and 2014.

Germany has a mature market with high healthcare expenditure and domestic pharmaceutical production but it is the cost-saving government policies that remain the largest barrier to future growth.

The performance of the market is forecast to accelerate, with an anticipated CAGR of 3.8% for the five-year period 2014 – 2019, which is expected to drive the market to a value of $44.8bn by the end of 2019.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Germany

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany

Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Germany economy

Reasons to buy

What was the size of the Germany pharmaceuticals market by value in 2014?

What will be the size of the Germany pharmaceuticals market in 2019?

What factors are affecting the strength of competition in the Germany pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitiors in Germany's pharmaceuticals market?

Companies mentioned

GlaxoSmithKline Plc, Novartis AG, Pfizer Inc.

Table of Contents

TABLE OF CONTENTS

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 8

Market value 8

Market Segmentation 9

Geography segmentation 9

Market share 10

Market Outlook 11

Market value forecast 11

Five Forces Analysis 12

Summary 12

Buyer power 13

Supplier power 15

New entrants 16

Threat of substitutes 18

Degree of rivalry 19

Leading Companies 21

GlaxoSmithKline Plc 21

Novartis AG 24

Pfizer Inc. 28

Macroeconomic Indicators 32

Country Data 32

Methodology 34

Industry associations 35

Related MarketLine research 35

Appendix 36

About MarketLine 36

List of Tables

Table 1: Germany pharmaceuticals market value: $ billion, 201014

Table 2: Germany pharmaceuticals market geography segmentation: $ billion, 2014

Table 3: Germany pharmaceuticals market share: % share, by value, 2014

Table 4: Germany pharmaceuticals market value forecast: $ billion, 201419

Table 5: GlaxoSmithKline Plc: key facts

Table 6: GlaxoSmithKline Plc: key financials ($)

Table 7: GlaxoSmithKline Plc: key financials (£)

Table 8: GlaxoSmithKline Plc: key financial ratios

Table 9: Novartis AG: key facts

Table 10: Novartis AG: key financials ($)

Table 11: Novartis AG: key financial ratios

Table 12: Pfizer Inc.: key facts

Table 13: Pfizer Inc.: key financials ($)

Table 14: Pfizer Inc.: key financial ratios

Table 15: Germany size of population (million), 201014

Table 16: Germany gdp (constant 2005 prices, $ billion), 201014

Table 17: Germany gdp (current prices, $ billion), 201014

Table 18: Germany inflation, 201014

Table 19: Germany consumer price index (absolute), 201014

Table 20: Germany exchange rate, 201014

List of Figures

Figure 1: Germany pharmaceuticals market value: $ billion, 201014

Figure 2: Germany pharmaceuticals market geography segmentation: % share, by value, 2014

Figure 3: Germany pharmaceuticals market share: % share, by value, 2014

Figure 4: Germany pharmaceuticals market value forecast: $ billion, 201419

Figure 5: Forces driving competition in the pharmaceuticals market in Germany, 2014

Figure 6: Drivers of buyer power in the pharmaceuticals market in Germany, 2014

Figure 7: Drivers of supplier power in the pharmaceuticals market in Germany, 2014

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2014

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2014

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2014

Figure 11: GlaxoSmithKline Plc: revenues & profitability

Figure 12: GlaxoSmithKline Plc: assets & liabilities

Figure 13: Novartis AG: revenues & profitability

Figure 14: Novartis AG: assets & liabilities

Figure 15: Pfizer Inc.: revenues & profitability

Figure 16: Pfizer Inc.: assets & liabilities

List of Tables

NA

List of Figures

NA

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports